Last reviewed · How we verify
NCT06263218
Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil
trial in CMV Infection in 500 participants. Status unknown.
30 July 2024
Quick facts
| Lead sponsor | Hospital do Rim e Hipertensão |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 1 October 2023 |
| Primary completion | 30 July 2024 |
| Estimated completion | 29 December 2024 |
| Sites | 1 location across Brazil |
Conditions studied
- CMV Infection — all drugs for CMV Infection →
- CMV Viremia — all drugs for CMV Viremia →
Sponsor
Hospital do Rim e Hipertensão
Who can join
18 and older, any sex, with CMV Infection or CMV Viremia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a single-center, non-interventional, retrospective study of data, at the level of the individual without identification, extracted from medical records of adult patients undergoing a kidney transplant procedure after 1st from January 2018 until reaching the sample size enrollment (around 500 individuals); this refers to the period of verification of individuals' eligibility for entry into the study. Individuals under strategy preemptive patients who developed CMV infection/disease within 12 months after transplantation. The data will be collected from date of transplant (including pre-transplant clinical history) until completion of at least 12 months after transplantation, or until graft loss, or recipient death or loss to follow-up, when/if applicable.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06263218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for CMV Infection
Currently open trials in the same condition.
- NCT06853184 — Study Evaluating the Efficacy and Safety of Artesunate · Phase 2 · recruiting
Other Hospital do Rim e Hipertensão trials
Trials by the same sponsor.
- NCT06116721 — Evaluation of APOL1 Gene Variants in Kidney Donors and Their Impact on Long-term Renal Function in Donors and Recipients · unknown
- NCT04801667 — Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients · Phase 4 · unknown
- NCT03468478 — Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06263218 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital do Rim e Hipertensão
- Last refreshed: 22 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06263218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing